Sucampo Reports Four
Sucampo Reports Fourth Quarter and Full Year 2014 Financial Results and Corporate Update
04. März 2015 06:30 ET | Sucampo Pharmaceuticals Inc
Strong Year-over-Year Revenue and Sales Growth for AMITIZA Significant Progress on Pipeline Programs and Strategic Plan Net Income and EPS Excluding Special Items in Line with 2014 Guidance...